General discussion, page-4297

First 4297 Last

Share
Profile

Follow
19stevo71

1,474 Posts.

172

17/02/21

19:31

Post #: 51092471
Share

Originally posted by Mattstamb: ↑

Hello IHLers.

First of all I would like to mention that I sold out of IHL some time ago. But I have kept it on my watchlist. But I am wondering what am I missing? Checking all the announcements etc I still see that IHL has yet to complete any trials on any of its drugs. Well apart from some pre-clinical work that is. Is no-one concerned by this? I see that they first announced the OSA formulation would hit the clinic in Sept 2019, and yet still nothing has happened. All I can see so far, is oil sales, and lots of announcements that have yet to amount to anything. So why is the market cap where it is? Is that Oil sales alone? I see lots of posts patting the BOD on the back for a job well done, but have yet to see anything material from them. Apart from fluffy announcements. I have yet to see any post from anyone who has any concern about the many announced promises not happening. And this seems very strange.

I see lots of potential here if the things from the announcements ever happen, but it does seem to be taking a long time. What am I missing? Have you set your own timelines for when you need trails to commence by to reassess your investment?

I don't mean this to be down ramping in anyway. The pipeline looks impressive. But any other company would have a far more robust discussion on how things are going than what is presented here as targets are missed.

Expand

Cool story matt's , still plenty of bags in it if you're keen to jump back in

IHL Price at posting: 24.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 16,142 more messages in this thread...

First 4297 Last

Add IHL (ASX) to my watchlist

General discussion, page-4297

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News